Citeline - Strengthening partnership: Strategies for business continuity and setting up robust specialty commercial drug supply chains

The requirements for biopharmaceuticals have never been more complex with emerging technologies, approvals, and shifting attitudes towards globalization. For life-saving therapies to be manufactured and reach patients requires a pharmaceutical supply chain that is not just reliable and secure but also sustainable.

During this roundtable we will discuss the supply chain challenges the pharmaceutical industry faces, their impacts and some of the partnering strategies available to mitigate them, with particular reference to specialty pharma and packaging challenges.

On August 31, Citeline will invite experts from Dr Reddy's, AstraZeneca, Biogen, Plus Therapeutics, and World Courier to discuss:
• What are the latest trends influencing specialty pharma supply chains?
• How does partnering impact the sourcing and manufacturing within pharma supply chains?
• How can partnering on packaging innovations drive environmental improvements in the pharma sector?
• What are some practical aspects to consider when specifying procurement requirements?
• How can we foster collaborative partnerships to enhance supply chain operations in the pharmaceutical industry?

Don’t miss this opportunity to ask your questions live and hear from accomplished experts.

Speakers:
• Christopher Engel, Service Development Director, World Courier
• Tobias Riedl, Head of Supply Chain, New Markets, Dr Reddy's
• Richard Farquharson, VP, Global Logistics, AstraZeneca
• Christina Pavlik, Global Supply Chain Strategy Manager, Biogen
• Dr Mark Hedrick, President & CEO, Plus Therapeutics